UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.

Medical costs continue to surge more than expected for health insurers.

UnitedHealth Group delivered a profit beat for the quarter, but not the kind that investors wanted to see. Heard on the ...

UnitedHealth Group stock fell more than 8% in early trading Tuesday as the Minnesota-based health care giant reported higher ...

I discuss and analyze UNH's cautious FY2025 guidance, attributing lower bottom-line to various factors. Click here to read my ...

UnitedHealth's stock was diving 3.7%, to pull back from a record high, and enough to pace the Dow's premarket losers, after ...

UnitedHealth’s stock took a hit in early trading Tuesday, after the healthcare giant beat third-quarter profit and revenue ...

Shares of UnitedHealth Group tumbled Tuesday as the company lowered its full-year outlook to reflect the impact of a February ...

UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. However, I rate it as a Buy. The company's long-term EPS growth target of 13-16% ...

UnitedHealth Group kicked off another round of earnings calls for major health insurance companies on Tuesday morning, where ...

The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...

On Wednesday, KeyBanc made an adjustment to the stock price target for UnitedHealth Group (NYSE:UNH), reducing it from $675.00 to $650.00, while maintaining an Overweight rating on the stock.